In partnership with:
This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with kasabach-merritt phenomenon
- Antiaggregants in Kasabach-Merritt phenomenon
- Israel Fernandez-Pineda, Juan Carlos Lopez-Gutierrez, Gloria Chocarro, Jose Bernabeu-Wittel, Gema Lucia Ramirez-Villar
- Pediatric Blood & Cancer, April 2013, Wiley
- DOI: 10.1002/pbc.24543